Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Remote, Smart Device-Based Cardiac Rehabilitation After Myocardial Infarction: A Pilot, Randomized Cross-Over SmartRehab Study

P. Wohlfahrt, D. Jenča, V. Melenovský, J. Mrázková, M. Šramko, M. Kotrč, M. Želízko, V. Adámková, F. Lopez-Jimenez, J. Piťha, J. Kautzner

. 2024 ; 2 (3) : 352-360. [pub] 20240620

Status neindexováno Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25014733

OBJECTIVE: To evaluate the effect of smart device-based telerehabilitation on Vo2peak in patients after myocardial infarction. PATIENTS AND METHODS: This was a pilot, single-center, randomized, cross-over study with a 3-month intervention. One month after myocardial infarction, patients had cardiopulmonary exercise testing and a 6-minute walking test (6MWT) and were randomly assigned 1:1. In the intervention group, patients received a smartwatch to track the recommended number of steps, which was individualized and derived from the 6MWT. A study nurse telemonitored adherence to the recommended number of steps a day. In the control group, 150 minutes a week of moderate-intensity physical activity was recommended. After 3 months study arms were crossed over, and study procedures were repeated after 3 months. RESULTS: Between June 1, 2019, and February 28, 2023, 64 patients were randomized, of which 61 (aged 51±10 years, 10% women) completed the study. Overall, the smart device-based telerehabilitation led to 2.31 mL/kg/min (95% CI, 1.25-3.37; P<.001) Vo2peak increase compared with the control treatment. Furthermore, there was a significant effect on weight (-1.50 kg; 95% CI, -0.39 to -2.70), whereas the effect on the 6MWT distance (4.7 m; 95% CI, -11.8 to 21.1) or Kansas City Quality of Life questionnaire score (0.98; 95% CI, -1.38 to 3.35) was not significant. CONCLUSION: Smart device-based cardiac rehabilitation may be a promising alternative for patients unable or unwilling to attend in-person cardiac rehabilitation. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT03926312.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25014733
003      
CZ-PrNML
005      
20250905141516.0
007      
ta
008      
250701s2024 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.mcpdig.2024.06.001 $2 doi
035    __
$a (PubMed)40206122
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Wohlfahrt, Peter $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u First Medical School, Charles University, Prague, Czech Republic
245    10
$a Remote, Smart Device-Based Cardiac Rehabilitation After Myocardial Infarction: A Pilot, Randomized Cross-Over SmartRehab Study / $c P. Wohlfahrt, D. Jenča, V. Melenovský, J. Mrázková, M. Šramko, M. Kotrč, M. Želízko, V. Adámková, F. Lopez-Jimenez, J. Piťha, J. Kautzner
520    9_
$a OBJECTIVE: To evaluate the effect of smart device-based telerehabilitation on Vo2peak in patients after myocardial infarction. PATIENTS AND METHODS: This was a pilot, single-center, randomized, cross-over study with a 3-month intervention. One month after myocardial infarction, patients had cardiopulmonary exercise testing and a 6-minute walking test (6MWT) and were randomly assigned 1:1. In the intervention group, patients received a smartwatch to track the recommended number of steps, which was individualized and derived from the 6MWT. A study nurse telemonitored adherence to the recommended number of steps a day. In the control group, 150 minutes a week of moderate-intensity physical activity was recommended. After 3 months study arms were crossed over, and study procedures were repeated after 3 months. RESULTS: Between June 1, 2019, and February 28, 2023, 64 patients were randomized, of which 61 (aged 51±10 years, 10% women) completed the study. Overall, the smart device-based telerehabilitation led to 2.31 mL/kg/min (95% CI, 1.25-3.37; P<.001) Vo2peak increase compared with the control treatment. Furthermore, there was a significant effect on weight (-1.50 kg; 95% CI, -0.39 to -2.70), whereas the effect on the 6MWT distance (4.7 m; 95% CI, -11.8 to 21.1) or Kansas City Quality of Life questionnaire score (0.98; 95% CI, -1.38 to 3.35) was not significant. CONCLUSION: Smart device-based cardiac rehabilitation may be a promising alternative for patients unable or unwilling to attend in-person cardiac rehabilitation. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT03926312.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jenča, Dominik $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Third Medical School, Charles University, Prague, Czech Republic
700    1_
$a Melenovský, Vojtěch $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Mrázková, Jolana $u Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Šramko, Marek $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u First Medical School, Charles University, Prague, Czech Republic
700    1_
$a Kotrč, Martin $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Želízko, Michael $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Adámková, Věra $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Lopez-Jimenez, Francisco $u Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN
700    1_
$a Piťha, Jan $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Medical and Dentistry School, Palacký University, Olomouc, Czech Republic
773    0_
$w MED00216588 $t Mayo Clinic proceedings Digital health $x 2949-7612 $g Roč. 2, č. 3 (2024), s. 352-360
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40206122 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250701 $b ABA008
991    __
$a 20250905141503 $b ABA008
999    __
$a ok $b bmc $g 2388176 $s 1251853
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 2 $c 3 $d 352-360 $e 20240620 $i 2949-7612 $m Mayo Clinic proceedings Digital health $n Mayo Clin Proc Digit Health $x MED00216588
LZP    __
$a Pubmed-20250701

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace